Bicillin L-A recalled over manufacturing violations

Recall date

July 10, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

Pfizer Inc. recalls Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only, Distributed…

Recall number

D-0544-2025

FDA classification

Class II

Brand / firm

Pfizer Inc.

Sold / distributed

Nationwide in the USA

Why it was recalled

CGMP Deviations; particulates identified during visual inspection

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Bicillin L-A (penicllin G benzathine injectable suspension), 1,200,000 units per 2 mL, 2 mL-vial, Rx Only, Distributed by Pfizer Inc., New York, NY 10001. Made in Austria, Carton NDC - 60793-701-10, Syringe NDC - 60793-701-02